- Home
- ARWR vs KNSL Comparison
ARWR vs KNSL Comparison
Compare ARWR & KNSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARWR | KNSL |
|---|---|---|
| Founded | 2003 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 8.8B |
| IPO Year | 1993 | 2016 |
Fundamental Metrics
Financial Performance| Metric | ARWR | KNSL |
|---|---|---|
| Price | $67.81 | $403.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 12 |
| Target Price | $73.70 | ★ $478.73 |
| AVG Volume (30 Days) | ★ 2.6M | 212.8K |
| Earning Date | 02-05-2026 | 02-12-2026 |
| Dividend Yield | N/A | ★ 0.17% |
| EPS Growth | N/A | ★ 16.09 |
| EPS | N/A | ★ 20.35 |
| Revenue | $829,448,000.00 | ★ $1,802,839,000.00 |
| Revenue This Year | N/A | $19.43 |
| Revenue Next Year | N/A | $7.38 |
| P/E Ratio | ★ N/A | $19.91 |
| Revenue Growth | ★ 23258.15 | 18.10 |
| 52 Week Low | $9.57 | $349.00 |
| 52 Week High | $76.76 | $512.76 |
Technical Indicators
Market Signals| Indicator | ARWR | KNSL |
|---|---|---|
| Relative Strength Index (RSI) | 57.08 | 54.28 |
| Support Level | $61.65 | $395.00 |
| Resistance Level | $68.24 | $416.41 |
| Average True Range (ATR) | 3.79 | 13.97 |
| MACD | -0.69 | 0.62 |
| Stochastic Oscillator | 45.29 | 62.06 |
Price Performance
Historical ComparisonAbout ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About KNSL Kinsale Capital Group Inc.
Kinsale Capital Group Inc is an insurance holding company. The company is engaged in offering property, casualty, and specialty insurance products. It offers specialty insurance products for allied health, healthcare, life sciences, professional, and a public entity. The company operates in only one reportable segment which is the Excess and Surplus Lines Insurance segment, which includes commercial excess and surplus lines liability and property insurance products through its underwriting divisions. The company generates revenues in the form of premiums and investment income.